In vivo investigation of the neuroprotective property of Convolvulus pluricaulis in scopolamine-induced cognitive impairments in Wistar rats

Journal: Indian Journal of Pharmacology Publication Year: 2011 | Volume: 43 | Issue: 5 | Pages: 520–525 Authors: Bihaqi S.W., Singh A.P., Tiwari M. Study Type: Preclinical — In vivo (rat) PMID: 22021993 | DOI:...

Sep 21, 2026 | 1 min read

Research Gist

This study examined whether an aqueous extract of Convolvulus pluricaulis, the species used as Shankhpushpi, could protect memory in male Wistar rats given scopolamine — a compound used in research to temporarily impair memory. Rats were pre-treated with the extract before scopolamine exposure, and results were compared with rivastigmine, a reference compound. Memory was assessed with the elevated plus maze and the Morris water maze. Pre-treated rats showed shorter transfer latency in the plus maze and better spatial memory in the water maze than untreated scopolamine rats. In the cortex and hippocampus, the extract reduced acetylcholinesterase activity — the enzyme that breaks down the memory-related messenger acetylcholine — and restored antioxidant defences including glutathione and superoxide dismutase. The authors suggest the extract works through both cholinergic and antioxidant pathways.

Key Learnings

  • Shankhpushpi extract improved spatial memory in the Morris water maze.
  • Transfer latency in the elevated plus maze, a learning and memory measure, was reduced.
  • Acetylcholinesterase activity was lower in the cortex and hippocampus.
  • Antioxidant defences such as glutathione and superoxide dismutase were restored.
  • This was a rat study using an induced-impairment model — it does not establish effects in people.